Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases

Background: Oligoclonal bands represent intrathecal immunoglobulin G (IgG) synthesis and play an important role in the diagnosis of multiple sclerosis (MS). Kappa free light chains (KFLC) are increasingly recognized as an additional biomarker for intrathecal Ig synthesis. However, there are limited data on KFLC in neurological diseases other than MS. Methods: This study, conducted at two centers, retrospectively enrolled 346 non-MS patients. A total of 182 patients were diagnosed with non-inflammatory and 84 with inflammatory neurological diseases other than MS. A further 80 patients were classified as symptomatic controls. Intrathecal KFLC production was determined using different approaches: KFLC index, Reiber’s diagram, Presslauer’s exponential curve, and Senel’s linear curve. Results: Matching results of oligoclonal bands and KFLC (Reiber’s diagram) were frequently observed (93%). The Reiber’s diagram for KFLC detected intrathecal KFLC synthesis in an additional 7% of the patient samples investigated (4% non-inflammatory; 3% inflammatory), which was not found by oligoclonal band detection. Conclusions: The determination of both biomarkers (KFLC and oligoclonal bands) is recommended for routine diagnosis and differentiation of non-inflammatory and inflammatory neurological diseases. Due to the high sensitivity and physiological considerations, the assessment of KFLC in the Reiber’s diagram should be preferred to other evaluation methods.

[1]  B. Weinshenker,et al.  CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis. , 2021, Mayo Clinic proceedings.

[2]  H. Tumani,et al.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis , 2021, Cells.

[3]  B. Mroczko,et al.  Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment , 2021, Journal of clinical medicine.

[4]  T. Zrzavy,et al.  Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study , 2021, Frontiers in Immunology.

[5]  A. Petersmann,et al.  Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern , 2021, Cells.

[6]  M. Süße,et al.  The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid , 2021, Journal of central nervous system disease.

[7]  M. Stangel,et al.  Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases , 2020, Diagnostics.

[8]  U. Dianzani,et al.  Intrathecal kappa free light chains as markers for multiple sclerosis , 2020, Scientific Reports.

[9]  M. Nauck,et al.  Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[10]  A. Petersmann,et al.  Free light chain kappa and the polyspecific immune response in MS and CIS – Application of the hyperbolic reference range for most reliable data interpretation , 2020, Journal of Neuroimmunology.

[11]  M. Nauck,et al.  Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[12]  H. Tumani,et al.  The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation , 2020, Cells.

[13]  M. Ciaccio,et al.  Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis. , 2020, Laboratory medicine.

[14]  P. Cavalla,et al.  Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders , 2019, Journal of Neuroimmunology.

[15]  T. Witte,et al.  Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis? , 2019, Diagnostics.

[16]  H. Reiber,et al.  Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[17]  J. Lewerenz,et al.  Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis , 2019, Front. Neurol..

[18]  A. Henningsson,et al.  Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis – a pilot study , 2019, Clinical chemistry and laboratory medicine.

[19]  A. Ludolph,et al.  CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort , 2019, Front. Immunol..

[20]  U. Rot,et al.  Intrathecal immunoglobulin synthesis: The potential value of an adjunct test. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[21]  A. Petersmann,et al.  Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands , 2018, European journal of neurology.

[22]  F. Deisenhammer,et al.  Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis , 2018, Clinical chemistry and laboratory medicine.

[23]  D. Murray,et al.  CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes , 2018, Clinical chemistry and laboratory medicine.

[24]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[25]  A. Enguix,et al.  Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm , 2017, Clinical chemistry and laboratory medicine.

[26]  G. Bellomo,et al.  Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs. , 2017, Clinical laboratory.

[27]  P. Hradílek,et al.  Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting , 2016, PloS one.

[28]  H. Tumani,et al.  Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study , 2016, Multiple sclerosis.

[29]  G. Giovannoni,et al.  The effects of intrathecal rituximab on biomarkers in multiple sclerosis. , 2016, Multiple sclerosis and related disorders.

[30]  A. Petzold Intrathecal oligoclonal IgG synthesis in multiple sclerosis , 2013, Journal of Neuroimmunology.

[31]  F. Fazekas,et al.  Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis , 2013, Multiple sclerosis.

[32]  E. Meinl,et al.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis , 2013, Nature Reviews Neurology.

[33]  K. Trinkaus,et al.  Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. , 2010, Archives of neurology.

[34]  P. Dayan,et al.  Effect of Antibiotic Pretreatment on Cerebrospinal Fluid Profiles of Children With Bacterial Meningitis , 2008, Pediatrics.

[35]  T. Brücke,et al.  Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis , 2008, Journal of Neurology.

[36]  Michael J. Ramsbottom,et al.  Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients , 2006, Journal of Neuroimmunology.

[37]  Hansotto Reiber,et al.  Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs , 2001, Journal of the Neurological Sciences.

[38]  G. Bernardi,et al.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[39]  I. Donaldson,et al.  Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. , 1990, Australian and New Zealand journal of medicine.

[40]  Deborah S. Smith,et al.  Cerebrospinal fluid changes after 48 hours of effective therapy for Hemophilus influenzae type B meningitis. , 1990, American journal of clinical pathology.

[41]  E. Thompson,et al.  Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[42]  B. Brooks,et al.  Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases , 1983, Annals of neurology.

[43]  H. Reiber Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. , 2003, Restorative neurology and neuroscience.